Using Science to Save Lives: Latest PEPFAR Results
Reflecting America’s commitment to saving lives affected by HIV/AIDS, PEPFAR is supporting countries in providing HIV prevention, treatment and care to their people.
-
The U.S. directly supported life-saving antiretroviral treatment for more than 3.9 million men, women and children worldwide as of September 30, 2011.
-
PEPFAR directly supported HIV testing and counseling for more than 9.8 million pregnant women in fiscal year 2011. PEPFAR supported antiretroviral drug prophylaxis to prevent mother-to-child transmission for more than 660,000 of these women who tested positive for HIV, allowing approximately 200,000 infants to be born HIV-free.
-
PEPFAR directly supported nearly 13 million people with care and support, including more than 4.1 million orphans and vulnerable children, in fiscal year 2011.
-
PEPFAR directly supported HIV counseling and testing for more than 40 million people in fiscal year 2011, providing a critical entry point to prevention, treatment, and care.
-
The U.S. is the first and largest donor to the Global Fund to Fight AIDS, Tuberculosis and Malaria. To date, the U.S. has provided more than $5.8 billion to the Fund. Of the estimated 6.6 million individuals in low- and middle-income countries who currently receive treatment, nearly 5.6 million receive support through PEPFAR bilateral programs, the Global Fund, or both.
